Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Guangzhou Pharmaceuticals sells second new base asset for a consideration of 583 million Yuan.

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that on February 28, 2025, Guangzhou Pharmaceuticals and Xingzheng Asset Management signed the "Confirmation Letter for the Delivery of New Base Assets" under the Basic Asset Purchase Agreement (Fourth Phase), confirming the sale of the second batch of new base assets to Xingzheng Asset Management and received a purchase price of 583 million yuan. Guangzhou Pharmaceuticals will use the accounts receivable under this transaction to securitize assets, allowing accounts receivable to be converted into more liquid cash assets to effectively leverage existing assets.